United States: Ninth Circuit Reverses In Part Dismissal Of Exchange Act Claims Against Pharmaceutical Manufacturer, Holding That Plaintiffs Adequately Pled Certain Alleged Misstatements And Loss Causation - Shearman & Sterling LLP
On January 11, 2021, the Ninth Circuit in an unpublished decision affirmed in part and reversed in part the dismissal at the pleading stage of Section 10(b) claims under the Exchange Act of 1934.
Full Article